Analyzing the solubility of fluoxetine hydrochloride in supercritical carbon dioxide

Jung, 2003, Gram to kilogram scale-up of supercritical antisolvent, 1683 Reverchon, 2003, Expanded micro-particles by supercritical antisolvent precipitation: interpretation of results, J. Supercritical Fluids, 26, 1, 10.1016/S0896-8446(02)00186-9 Kayrak, 2003, Micronization of ibuprofen by RESS, J. Supercritical Fluids, 26, 17, 10.1016/S0896-8446(02)00248-6 Turk, 2009, Manufacture of submicron drug particles with enhanced dissolution behaviour by rapid expansion processes, J. Supercritical Fluids, 47, 537, 10.1016/j.supflu.2008.09.008 Cocero, 2009, Encapsulation and co-precipitation processes with supercritical fluids: fundamentals and applications, J. Supercritical Fluids, 47, 546, 10.1016/j.supflu.2008.08.015 Nunes, 2011, Dense CO2 as a solute, co-solute or co-solvent in particle formation processes: a review, Materials, 4, 2017, 10.3390/ma4112017 Zeinolabedini Hezave, 2010, Crystallization of micro particles of sulindac using rapid expansion of supercritical solution, J. Crystal Growth, 312, 3373, 10.1016/j.jcrysgro.2010.07.033 Zeinolabedini Hezave, 2010, Micronization of creatine monohydrate via Rapid Expansion of Supercritical Solution (RESS), J. Supercritical Fluids, 55, 316, 10.1016/j.supflu.2010.05.009 Zeinolabedini Hezave, 2012, Recrystallization of microparticles of fenoprofen using rapid expansion of supercritical solution, J. Dispersion Science and Technology, 33, 1106, 10.1080/01932691.2011.599231 Luicen, 2000, Solubilities of solid mixtures in supercritical carbon dioxide: a review, J. Supercritical Fluids, 17, 111, 10.1016/S0896-8446(99)00048-0 Alessi, 1996, Particle production of steroid drugs using supercritical fluid processing, Industrial and Engineering Chemistry Research, 35, 4718, 10.1021/ie960202x Foster, 2003, Processing pharmaceutical compounds using dense gas technology, Industrial and Engineering Chemistry Research, 42, 6476, 10.1021/ie030219x Subramanyam, 1997, Pharmaceutical processing with supercritical carbon dioxide, J. Pharmaceutical Sciences, 86, 885, 10.1021/js9700661 Jung, 2001, Particle design using supercritical fluid: literature and patent survey, J. Supercritical Fluids, 20, 179, 10.1016/S0896-8446(01)00064-X Coimbra, 2006, Cubic equation-of-state correlation of the solubility of some anti-inflammatory drugs in supercritical carbon dioxide, Fluid Phase Equilibria, 239, 188, 10.1016/j.fluid.2005.11.028 Christov, 2002, High-pressure fluid phase equilibria experimental methods and systems investigated (1994–1999), Fluid Phase Equilibria, 202, 153, 10.1016/S0378-3812(02)00096-1 Rosa, 2005, Supercritical technology in Brazil: system investigated (1994–2003), J. Supercritical Fluids, 34, 109, 10.1016/j.supflu.2004.11.003 Güçlü-Üstündağ, 2005, Solubility behavior of ternary systems of lipids in supercritical carbon dioxide, J. Supercritical Fluids, 36, 1, 10.1016/j.supflu.2005.03.002 Prajapati, 2004, Recent advances in the application of supercritical fluids for carboncarbon bond formation in organic synthesis, Tetrahedron, 60, 815, 10.1016/j.tet.2003.10.075 Yang, 2005, Modeling of the solubility of aromatic compounds in supercritical carbon dioxide–cosolvent systems using SAFT equation of state, J. Supercritical Fluids, 33, 99, 10.1016/j.supflu.2004.05.008 Sane, 2003, A semi continuous flow apparatus for measuring the solubility of opaque solids in supercritical solutions, J. Supercritical Fluids, 28, 277, 10.1016/S0896-8446(03)00046-9 Kopcak, 2005, Caffeine solubility in supercritical carbon dioxide/co-solvent mixtures, J. Supercritical Fluids, 34, 209, 10.1016/j.supflu.2004.11.016 Kumar Jha, 2005, Correlations for binary phase equilibria in high pressure carbon dioxide, Fluid Phase Equilibria, 238, 174, 10.1016/j.fluid.2005.09.029 Guha, 2001, Modeling of ternary solubilities of organics in supercritical carbon dioxide, Fluid Phase Equilibria, 187, 255, 10.1016/S0378-3812(01)00540-4 Liu, 1996, Solubility of organic solid mixture in supercritical fluids, J. Supercritical Fluids, 9, 152, 10.1016/S0896-8446(96)90026-1 Kumar, 1988, Modelling solubility of solids in supercritical fluids with density as the independent variable, J. Supercritical Fluids, 1, 15, 10.1016/0896-8446(88)90005-8 Chrastil, 1982, Solubility of solids and liquids in supercritical gases, J. Physical Chemistry, 86, 3016, 10.1021/j100212a041 Mitra, 1991, An empirical method to predict solubility in supercritical fluids, J. Chromatographic Science, 29, 305, 10.1093/chromsci/29.7.305 Bartle, 1991, Solubilities of solids and liquids of low volatility in supercritical carbon dioxide, J. Physical and Chemical Reference Data, 20, 713, 10.1063/1.555893 Mendez-Santiago, 1999, The solubility of solids in supercritical fluids, Fluid Phase Equilibria, 158, 501, 10.1016/S0378-3812(99)00154-5 Shamsipur, 2004, Solubilities of some 1-hydroxy-9,10-anthraquinone derivatives in supercritical carbon dioxide, J. Supercritical Fluids, 32, 47, 10.1016/j.supflu.2004.01.006 Huang, 2005, Solubilities of xanthone and xanthene in supercritical CO2, Fluid Phase Equilibria, 238, 26, 10.1016/j.fluid.2005.09.008 Bristow, 2001, Solubility analysis of drug compounds in supercritical carbon dioxide using static and dynamic extraction systems, Industrial and Engineering Chemistry Research, 40, 1732, 10.1021/ie0002834 Huang, 2005, Representing dyestuff solubility in supercritical carbon dioxide with several density based correlations, Fluid Phase Equilibria, 236, 136, 10.1016/j.fluid.2005.07.012 Wong, 1974, A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-trifluoromethylphenoxy)-n-methyl-3-phenylpropylamine, Life Sciences, 15, 471, 10.1016/0024-3205(74)90345-2 Hagerman, 1999 Verispan, Top 200 Generic Drugs by Units in 2010, Drug Topics, http://drugtopics.modernmedicine.com/drugtopics/data/articlestandard//drugtopics/252011/727243/article.pdf. Zeinolabedini Hezave, 2012, Solubility measurement of diclofenac acid in the supercritical CO2, J. Chemical & Engineering Data, 57, 1659, 10.1021/je200012x Zeinolabedini Hezave, 2011, Cetirizine solubility in supercritical CO2 at different pressures and temperatures, J. Supercritical Fluids, 58, 198, 10.1016/j.supflu.2011.05.017 Zeinolabedini Hezave, 2012, Solubility of sulindac in the supercritical carbon dioxide: experimental and modeling approach, J. Supercritical Fluids, 68, 39, 10.1016/j.supflu.2012.04.006 Zeinolabedini Hezave, 2012, Measurement and modeling of mefenamic acid solubility in supercritical carbon dioxide, Fluid Phase Equilibria, 313, 140, 10.1016/j.fluid.2011.09.031 Yamini, 1998, Solubility of dihydroxybenzene isomers in supercritical carbon dioxide, Fluid Phase Equilibria, 152, 299, 10.1016/S0378-3812(98)00385-9 Su, 2008, Measurement and correlation for the solid solubility of non-steroidal anti-inflammatory drugs (NSAIDs) in supercritical carbon dioxide, J. Supercritical Fluids, 43, 438, 10.1016/j.supflu.2007.08.006 Hojjati, 2007, Solubility of some statin drugs in supercritical carbon dioxide and representing the solute solubility data with several density-based correlations, J. Supercritical Fluids, 41, 187, 10.1016/j.supflu.2006.10.006 Miller, 1996, Solubility of polycyclic aromatic hydrocarbons in supercritical carbon dioxide from 313K to 523K and pressures from 100bar to 450bar, J. Chemical and Engineering Data, 41, 779, 10.1021/je960022u Kraska, 2002, Correlation of the solubility of low-volatile organic compounds in near- and supercritical fluids. Part I. Applications to adamantane and β-carotene, J. Supercritical Fluids, 23, 209, 10.1016/S0896-8446(02)00003-7